Post-resuscitative management of the asphyxiated term and preterm infant

Seminars in Neonatology

Volumn 6, Issue 3, 2001, Pages 271-282

  Cornette, Luc ^a   Levene, Malcolm I ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Animal model; Brain; Clinical trial; Hypoxic ischaemic encephalopathy; Neonate; Neuroprotection; Newborn

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ANTIBODY; ANTICONVULSIVE AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CASPASE INHIBITOR; CELL ADHESION MOLECULE; CREATINE; CYTOKINE; DOBUTAMINE; DOPAMINE; FRESH FROZEN PLASMA; FRUCTOSE 1,6 BISPHOSPHATE; GLUCOSE; HYPERTONIC SOLUTION; INOTROPIC AGENT; MAGNESIUM; MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTROPHIC FACTOR; NITRIC OXIDE SYNTHASE INHIBITOR; PHENOBARBITAL; PLASMA SUBSTITUTE; SCAVENGER; SODIUM CHANNEL BLOCKING AGENT; SODIUM CHLORIDE; THEOPHYLLINE; UNINDEXED DRUG; VITAMIN K GROUP;

ARTICLE; BLOOD CLOTTING DISORDER; BRAIN EDEMA; BRAIN HYPOXIA; BRAIN ISCHEMIA; CARDIOPULMONARY INSUFFICIENCY; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; HUMAN; HYPOTENSION; INDUCED HYPOTHERMIA; INFECTION; KIDNEY FAILURE; NEUROPROTECTION; NEWBORN; NONHUMAN; NUTRITIONAL SUPPORT; PERINATAL ASPHYXIA; PREMATURITY; RESUSCITATION; SEIZURE; SIDE EFFECT;

EID: 0034857568     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1053/siny.2001.0055     Document Type: Article

References (92)

1. Cerebral energy metabolism studied with phosphorus NMR spectroscopy in normal and birth-asphyxiated infants
2. Hypoxic and ischemic central nervous system disorders in infants and children
3. Perinatal asphyxia: MR findings in the first 10 days
4. Early MR features of hypoxic-ischemic brain injury in neonates with periventricular densities on sonograms
5. Cerebrospinal nerve growth factor - A marker of asphyxia?
6. Detection of DNA damage induced by apoptosis in the rat brain following incomplete ischemia
7. Post-resuscitation left ventricular systolic and diastolic dysfunction. Treatment with dobutamine
8. A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia
9. Prognostic value of the electroencephalogram in neonatal asphyxia
10. Management of the asphyxiated full term infant
11. Measurement of the urinary lactate: Creatinine ratio for the early identification of newborn infants at risk for hypoxic-ischemic encephalopathy
12. Carbon dioxide protects the perinatal brain from hypoxic-ischemic damage: An experimental study in the immature rat
13. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension
14. Value of intracranial pressure monitoring of asphyxiated infants
15. Medical management of raised intracranial pressure after severe birth asphyxia
16. Prevention of hypoxic/ischemic damage with dexamethasone is dependent on age and not influenced by fasting
17. Effect of glucose on perinatal hypoxic-ischemic brain damage
18. Posthypoxic glucose supplement reduces hypoxic-ischemic brain damage in the neontal rat
19. Glucose transporters, hexokinase, and phosphofructokinase in brain of rats with perinatal asphyxia
20. Management and outcome of birth asphyxia
21. Consequences of neonatal seizures in the rat: Morphological and behavioral effects
22. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia (Cochrane Review)
23. Systematic review of therapy after hypoxicischaemic brain injury in the perinatal period
24. 2 receptors
25. Markers of asphyxia and neonatal brain injury
26. Can asphyxiated infants at risk for neonatal seizures be rapidly identified by current high-risk markers?
27. Assessment of neonatal encephalopathy by amplitudo-integrated electroencephalography
28. Reperfusion injury as the mechanism of brain damage after perinatal asphyxia
29. Hypoxic-ischemic brain injury in the newborn. Cellular mechanisms and potential strategies for neuroprotection
30. Oxygen-derived free radicals in post-ischemic tissue injury
31. Excitatory amino acids in the cerebrospinal fluid of asphyxiated infants: Relationship to hypoxic-ischemic encephalopathy
32. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat
33. The excitatory amino acid antagonist kynurenic acid administered after hypoxic ischemia in neonatal rat offers neuroprotection
34. Posthypoxic treatment with MK-80I reduces hypoxic/ischemic damage in the neonatal rat
35. Interaction of the chiral forms of ketamine with opioid, phencyclidine, and muscarinic receptors
36. Neuroprotective, anesthetic, and cardiovascular effects of the NMDA antagonist, CNS 5161A, in isoflurane-anesthetized lambs
37. Desmehyl tirilazad improves neurologic function after hypoxic ischemic brain injury in piglets
38. Interventions for perinatal hypoxic-ischaemic encephalopathy
39. Pathophysiology of perinatal brain damage
40. Reduction of perintal hypoxic-ischemic brain damage with allopurinol
41. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics and electrical brain activity
42. Effects of hypercapnia on prostanoid and cAMP production by cerebral microvascular cell cultures
43. Pharmacological modulation of voltage-gated Na+ channels: A rational and effective strategy against ischemic brain damage
44. Preservation of cerebrovascular tone and reactivity by sodium channel inhibition in experimental prolonged asphyxia in piglets
45. Prognostic significance of cerebrospinal fluid cyclic adenosine monophosphate in neonatal asphyxia
46. Fructose-1,6-biphosphate after hypoxic ischemic injury is protective to neonatal rat brain
47. Anoxic ATP depletion in neonatal mice brainstem is prevented by creatine supplementation
48. Neonatal asphyxia pallida treated with hypothermia alone or with hypothermia and transfusion of oxygenated blood
49. The use of hypothermia: A role in the treatment of neonatal asphyxia?
50. Neuroprotection with prolonged head cooling started before postischemic seizures in fetal sheep
51. Treatment of traumatic brain injury with moderate hypothermia
52. Selective head cooling in newborn infants after perinatal asphyxia: A safety study
53. Cerebral hypothermia is not neuroprotective when started after postischemic seizures in fetal sheep
54. Treatment of hypoxic-ischaemic brain damage by moderate hypothermia
55. Neurodevelopmental outcome of infants treated with head cooling and mild hypothermia after perinatal asphyxia
56. Pilot study of treatment with whole body hypothermia for neonatal encephalopathy
57. Brain damage in preterm newborns: Might enhancement of developmentally regulated endogenous protection open a door for prevention?
58. Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors
59. Asphyxial brain injury-the role of the IGF system
60. Possible protective role of growth hormone in hypoxia-ischemia in neonatal rats
61. Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage
62. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury
63. Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration
64. Commentary. Mechanisms of tumor necrosis factor alpha action on neurodegeneration: Interactions with insulin-like growth factor-1
65. Interleukin-6 in the cerebrospinal fluid after perinatal asphyxia is related to early and late neurological manifestations
66. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis
67. Kainic acid induced expression of interleukln-1 receptor antagonist mRNA in the rat brain
68. Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cereberal ischemia in mice
69. IL-10 reduces rat brain injury following focal stroke
70. Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives
71. TNF alpha and IL-1 beta mediate intercellular adhesion motecule-1 induction via microglia-astrocyte interaction in CNS radiation injury
72. Anti-P-selectin antibody attenuates rat brain ischemic injury
73. Caspases: Killer proteases
74. Caspase inhibitor affords neuroprotecion with delayed administration in a rat model of neonatal hyoxicischaemic brain injury
75. Caspases determine the vulnerability of oligodendrocytes in the ischemic brain
76. Cell adhesion molecules in neural plasticity and pathology: Similar mechanisms, distinct organizations?
77. Inhibitor of nitric oxide synthesis reduces hypoxic/ischemic brain damage in the neonatal rat
78. Pearce WJ L-NAME reduces infarct volume in a filament model of transient middle cerebral artery occlusion in the rat pup
79. Nitric oxide synthase inhibition attenuates delayed vasodilatation and increases injury after cerebral ischemia in fetal sheep
80. Metabolic disturbances in hippocampal slices of fetal guinea pigs during and after oxygen-glucose deprivation: Is nitric oxide involved?
81. The use of a calcium-channel blocker, nicardipine, for severely asphyxiated newborn infants
82. Use of polyethylene glycol-bound superoxide dismutase, polyethylene glycol-bound catalase, and nimodipine to prevent hypoxic ischemic injury to the brain of newborn pigs
83. Low dose flunarizine protects the fetal brain from ischemic injury in sheep
84. Magnesium protects against neurological deficit after brain injury
85. Can magnesium sulfate reduce the risk of cerebral palsy in very low birth-weight infants?
86. Modulation of magnesium of N-methyl-D-aspartate receptors in developing human brain
87. Prevention by magnesium of excitotoxic neuronal death in the developing brain: An animal model for clinical intervention studies
88. Hypoxia-induced neurotransmitter deficits in neonatal rats are partially corrected by exogenous GM1 ganglioside
89. Pretreatment with monosialoganglioside GM1 protects the brain of fetal sheep against hypoxic/ischemic injury without causing systemic compromise
90. An international network for evaluating neuroprotective therapy after severe birth asphyxia
91. Current status of neuroprotection trials for traumatic brain injury: Lessons from animal models and clinical studies